Source comparison
Dosing Practicality: Oral Convenience vs Injectable Precision
MK-677 is administered orally once daily, typically at bedtime to minimize daytime appetite stimulation (ghrelin mimicry increases hunger signaling). Standard research doses range from 10mg (minimum effective threshold) to 25mg (near-maximal GH response). Oral
This comparison does not assign a generated winner or score.
- MK-677 is administered orally once daily, typically at bedtime to minimize daytime appetite stimulation (ghrelin mimicry increases hunger signaling). Standard research doses range from 10mg (minimum effective threshold) to 25mg (near-maximal GH response). Oral bioavailability is approximately 60%, and the compound is chemically stable at room temperature for 12+ months when stored in a sealed container away from moisture. This makes MK-677 the most logistically straightforward GH secretagogue for long-duration studies. No reconstitution, no refrigeration, no injection training required.
- Tesamorelin + Ipamorelin requires reconstitution with bacteriostatic water, refrigerated storage at 2–8°C post-mixing, and daily subcutaneous injection. Typical research protocols use Tesamorelin at 1–2mg and Ipamorelin at 200–300mcg per dose, administered once daily before bed. The reconstituted solution remains stable for 28 days under refrigeration. Temperature excursions above 8°C cause irreversible peptide degradation that potency testing at the research level cannot detect. Injection technique matters: subcutaneous administration into abdominal adipose tissue produces more consistent absorption than deltoid or thigh sites due to localized blood flow differences.
- For multi-month studies, the convenience advantage of MK-677 is offset by the need for periodic cycling to mitigate receptor desensitization. Teams using MK-677 for 12+ weeks typically implement a 4-week washout every 8–12 weeks to restore pituitary sensitivity. The Tesamorelin + Ipamorelin blend doesn't require cycling in the same way. Its pulsatile mechanism inherently prevents the chronic receptor occupancy that drives desensitization. Explore our full peptide collection to compare synthesis quality across GH secretagogues.